End-of-day quote
Moscow Micex - RTS
18:00:00 2022-07-07 EDT
|
5-day change
|
1st Jan Change
|
12.5
RUB
|
-0.03%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
20,253
|
11,980
|
82,444
|
107,208
|
106,063
|
95,350
|
Enterprise Value (EV)
1 |
51,767
|
66,705
|
122,197
|
155,920
|
135,654
|
126,988
|
P/E ratio
|
-1.55
x
|
-0.52
x
|
-6.78
x
|
15.1
x
|
-112
x
|
428
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.42
x
|
0.27
x
|
1.79
x
|
2.73
x
|
2.4
x
|
1.61
x
|
EV / Revenue
|
1.07
x
|
1.49
x
|
2.65
x
|
3.97
x
|
3.08
x
|
2.15
x
|
EV / EBITDA
|
-22.3
x
|
-18.3
x
|
694
x
|
68.9
x
|
62.6
x
|
22.2
x
|
EV / FCF
|
-5.44
x
|
-12.9
x
|
-61.5
x
|
-7.86
x
|
5.7
x
|
18.6
x
|
FCF Yield
|
-18.4%
|
-7.78%
|
-1.63%
|
-12.7%
|
17.5%
|
5.39%
|
Price to Book
|
-1.47
x
|
-0.33
x
|
-3.5
x
|
-18.8
x
|
-15.9
x
|
-14.8
x
|
Nbr of stocks (in thousands)
|
2,330,645
|
2,330,647
|
6,708,243
|
7,630,434
|
7,630,434
|
7,630,434
|
Reference price
2 |
8.690
|
5.140
|
12.29
|
14.05
|
13.90
|
12.50
|
Announcement Date
|
6/19/18
|
4/26/19
|
4/29/20
|
4/27/21
|
7/17/23
|
7/17/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
48,253
|
44,664
|
46,049
|
39,267
|
44,104
|
59,048
|
EBITDA
1 |
-2,320
|
-3,638
|
176
|
2,264
|
2,167
|
5,724
|
EBIT
1 |
-3,791
|
-4,770
|
-711
|
1,247
|
997
|
4,318
|
Operating Margin
|
-7.86%
|
-10.68%
|
-1.54%
|
3.18%
|
2.26%
|
7.31%
|
Earnings before Tax (EBT)
1 |
-13,140
|
-22,757
|
-8,745
|
-643
|
-1,442
|
411
|
Net income
1 |
-13,097
|
-22,977
|
-8,855
|
6,351
|
-950
|
223
|
Net margin
|
-27.14%
|
-51.44%
|
-19.23%
|
16.17%
|
-2.15%
|
0.38%
|
EPS
2 |
-5.619
|
-9.859
|
-1.813
|
0.9331
|
-0.1245
|
0.0292
|
Free Cash Flow
1 |
-9,509
|
-5,190
|
-1,988
|
-19,825
|
23,791
|
6,840
|
FCF margin
|
-19.71%
|
-11.62%
|
-4.32%
|
-50.49%
|
53.94%
|
11.58%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
1,097.87%
|
119.5%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
3,067.32%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/19/18
|
4/26/19
|
4/29/20
|
4/27/21
|
7/17/23
|
7/17/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
31,514
|
54,725
|
39,753
|
48,712
|
29,591
|
31,638
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-13.58
x
|
-15.04
x
|
225.9
x
|
21.52
x
|
13.66
x
|
5.527
x
|
Free Cash Flow
1 |
-9,509
|
-5,190
|
-1,988
|
-19,825
|
23,791
|
6,840
|
ROE (net income / shareholders' equity)
|
183%
|
90.8%
|
29.3%
|
6.78%
|
15.4%
|
-3.41%
|
ROA (Net income/ Total Assets)
|
-5.6%
|
-8.21%
|
-1.36%
|
1.79%
|
1.35%
|
6.63%
|
Assets
1 |
234,021
|
279,880
|
651,007
|
354,686
|
-70,329
|
3,365
|
Book Value Per Share
2 |
-5.930
|
-15.80
|
-3.510
|
-0.7500
|
-0.8700
|
-0.8400
|
Cash Flow per Share
2 |
0.2800
|
0.2200
|
0.1300
|
0.1300
|
0.2300
|
0.1100
|
Capex
1 |
365
|
645
|
1,819
|
1,692
|
699
|
694
|
Capex / Sales
|
0.76%
|
1.44%
|
3.95%
|
4.31%
|
1.58%
|
1.18%
|
Announcement Date
|
6/19/18
|
4/26/19
|
4/29/20
|
4/27/21
|
7/17/23
|
7/17/23
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 1.1B | | -53.68% | 10.44B | | -45.65% | 8.68B | | -26.18% | 6.45B | | -7.49% | 5.98B | | +85.61% | 4.91B | | -3.80% | 4.57B | | +5.73% | 4.49B | | -26.42% | 4.1B | | -19.63% | 2.58B |
Other Drug Retailers
|